Employees Retirement System of Texas decreased its position in Stryker Corporation (NYSE:SYK) by 5.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,000 shares of the medical technology company’s stock after selling 1,000 shares during the period. Employees Retirement System of Texas’ holdings in Stryker Corporation were worth $2,220,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of the business. Acrospire Investment Management LLC bought a new position in shares of Stryker Corporation during the second quarter valued at about $111,000. Bollard Group LLC increased its stake in shares of Stryker Corporation by 0.4% during the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 3 shares in the last quarter. Motco increased its stake in shares of Stryker Corporation by 50.7% during the second quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 278 shares in the last quarter. Bruderman Asset Management LLC bought a new position in shares of Stryker Corporation during the second quarter valued at approximately $150,000. Finally, James Investment Research Inc. bought a new stake in shares of Stryker Corporation during the second quarter valued at approximately $155,000. Hedge funds and other institutional investors own 74.09% of the company’s stock.
A number of research firms have commented on SYK. Zacks Investment Research upgraded shares of Stryker Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday. Cowen and Company set a $160.00 target price on shares of Stryker Corporation and gave the company a “buy” rating in a research note on Friday, October 6th. Robert W. Baird restated a “hold” rating and set a $161.00 target price on shares of Stryker Corporation in a research note on Friday. Piper Jaffray Companies reiterated a “buy” rating and set a $156.00 price target on shares of Stryker Corporation in a report on Friday. Finally, Wells Fargo & Company boosted their price objective on shares of Stryker Corporation from $160.00 to $166.00 in a research report on Friday. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $149.81.
Shares of Stryker Corporation (NYSE SYK
) traded up 5.708% during midday trading on Friday, reaching $157.315. The company’s stock had a trading volume of 1,031,650 shares. The company has a market cap of $58.85 billion, a price-to-earnings ratio of 35.115 and a beta of 0.80. The stock has a 50-day moving average of $144.88 and a 200 day moving average of $141.56. Stryker Corporation has a 12 month low of $106.48 and a 12 month high of $159.20.
Stryker Corporation (NYSE:SYK) last issued its earnings results on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.50 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The business had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.97 billion. During the same period in the previous year, the company posted $1.39 EPS. The firm’s revenue was up 6.1% compared to the same quarter last year. On average, analysts predict that Stryker Corporation will post $6.44 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be paid a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.14%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s dividend payout ratio is presently 37.95%.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now owns 88,207 shares in the company, valued at approximately $12,909,976.52. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the sale, the insider now directly owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. 7.40% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Stryker Corporation (NYSE:SYK) Stake Lessened by Employees Retirement System of Texas” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.dispatchtribunal.com/2017/10/27/employees-retirement-system-of-texas-has-2-22-million-position-in-stryker-corporation-syk.html.
Stryker Corporation Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.